When the highly infectious Delta variant hit China in the summer, some public health experts were hopeful that the country could soon receive an immunity boost from BioNTech’s highly effective mRNA Covid-19 vaccine.
China was ready to approve Western mRNA vaccines months ago. Why is it still holding off?